Bill
AB 382
Revises provisions relating to health insurance coverage for biomarker testing. (BDR 57-913)
2025 Regular Session
Introduced by Joe Dalia and 15 co-sponsors
Expands and standardizes insurance coverage to include biomarker testing for any medical condition when supported by medical or scientific evidence, beyond cancer-focused medical n
(Pursuant to Joint Standing Rule No. 14.3.1, no further action allowed.)